Mauro Ferrari, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 5,294 shares at $37.80 ($201K) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Scheduled sale ($201k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.80 | 2,147 | $81K | 40.4% |
| 2 | $37.80 | 2,147 | $81K | 40.4% |
| 3 | $38.63 | 1,000 | $39K | 19.2% |
| Total | $37.96 avg | 5,294 | $201K | 100% |
| Filing → |
| ARWR | SELL | 2021-12-29 | $454K | — | Filing → |
| ARWR | SELL | 2020-10-13 | $480K | — | Filing → |
| ARWR | SELL | 2019-06-28 | $980K | — | Filing → |